127 related articles for article (PubMed ID: 2223683)
21. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy.
Klaiber EL; Broverman DM; Vogel W; Peterson LG; Snyder MB
Psychoneuroendocrinology; 1997 Oct; 22(7):549-58. PubMed ID: 9373888
[TBL] [Abstract][Full Text] [Related]
22. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
Thom MH; Collins WP; Studd JW
Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
[TBL] [Abstract][Full Text] [Related]
23. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens.
Savvas M; Studd JW; Norman S; Leather AT; Garnett TJ; Fogelman I
Br J Obstet Gynaecol; 1992 Sep; 99(9):757-60. PubMed ID: 1420016
[TBL] [Abstract][Full Text] [Related]
24. Are high levels of oestradiol after implants associated with features of dependence?
O'Leary A; Bowen-Simpkins P; Tejura H; Rajesh U
Br J Obstet Gynaecol; 1999 Sep; 106(9):960-3. PubMed ID: 10492109
[TBL] [Abstract][Full Text] [Related]
25. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women.
Studd JW; Holland EF; Leather AT; Smith RN
Br J Obstet Gynaecol; 1994 Sep; 101(9):787-91. PubMed ID: 7947528
[TBL] [Abstract][Full Text] [Related]
26. Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles.
Pirwany IR; Sattar N; Greer IA; Packard CJ; Fleming R
Hum Reprod; 2002 Mar; 17(3):825-9. PubMed ID: 11870144
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
28. Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants.
Britto R; Araújo L; Barbosa I; Silva L
Gynecol Endocrinol; 2012 Oct; 28(10):767-9. PubMed ID: 22397585
[TBL] [Abstract][Full Text] [Related]
29. Prolonged endometrial stimulation associated with oestradiol implants.
Gangar KF; Fraser D; Whitehead MI; Cust MP
BMJ; 1990 Feb; 300(6722):436-8. PubMed ID: 2107895
[TBL] [Abstract][Full Text] [Related]
30. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants.
Savvas M; Bishop J; Laurent G; Watson N; Studd J
Br J Obstet Gynaecol; 1993 Feb; 100(2):154-6. PubMed ID: 8476808
[TBL] [Abstract][Full Text] [Related]
31. [Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women].
Tsvetkov K; Monastirska M; Angelova M
Akush Ginekol (Sofiia); 2008; 47 Suppl 1():29-32. PubMed ID: 18935856
[No Abstract] [Full Text] [Related]
32. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.
Smith RN; Studd JW; Zamblera D; Holland EF
Br J Obstet Gynaecol; 1995 Jun; 102(6):475-84. PubMed ID: 7632640
[TBL] [Abstract][Full Text] [Related]
33. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
[TBL] [Abstract][Full Text] [Related]
34. Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study.
Demetrio FN; Rennó J; Gianfaldoni A; Gonçalves M; Halbe HW; Filho AH; Gorenstein C
Arch Womens Ment Health; 2011 Dec; 14(6):479-86. PubMed ID: 22016254
[TBL] [Abstract][Full Text] [Related]
35. Symptomatology and hormone profile of menopausal Nigerians.
Akingbade OA; Bolarinwa AF; Subbarao VV
Afr J Med Med Sci; 1990 Jun; 19(2):133-7. PubMed ID: 2115729
[TBL] [Abstract][Full Text] [Related]
36. Successful estradiol treatment of psychotic symptoms in the premenstrual phase: a case report.
Korhonen S; Saarijärvi S; Aito M
Acta Psychiatr Scand; 1995 Sep; 92(3):237-8. PubMed ID: 7484205
[No Abstract] [Full Text] [Related]
37. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
Tsvetkov Ts; Tsvetkov K; Petkova U
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
[No Abstract] [Full Text] [Related]
38. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
Magos AL; Brincat M; Studd JW
Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1629-33. PubMed ID: 3087550
[TBL] [Abstract][Full Text] [Related]
39. Long-term hormone implant therapy--effects on lipoproteins and steroid levels in post-menopausal women.
Fletcher CD; Farish E; Hart DM; Barlow DH; Gray CE; Conaghan CJ
Acta Endocrinol (Copenh); 1986 Mar; 111(3):419-23. PubMed ID: 3962567
[TBL] [Abstract][Full Text] [Related]
40. Oestrogen replacement after oophorectomy: comparison of patches and implants.
Anderson CH; Raju SK; Forsling ML; Wheeler MJ
BMJ; 1992 Jul; 305(6845):90-1. PubMed ID: 1449552
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
